Gene Bridges Announces Distribution Agreement with CAMBIO for Red/ET Recombination Kits
DRESDEN, Germany - Gene Bridges GmbH announced today, that CAMBIO Ltd., Cambridge, UK, has agreed to distribute Gene Bridges' Red/ET Recombination Kits in the United Kingdom & Ireland. "We are very pleased that a distribution organisation like CAMBIO, with such a strong market presence and reputation throughout United Kingdom has agreed to distribute our Red/ET Recombination Kits" says Gary Stevens, CEO of Gene Bridges. "Red/ET Recombination, also known as ET cloning or Lambda-mediated cloning, allows DNA constructs to be designed and created without size or site restrictions." The agreement includes the distribution of BAC Modification Kit, BAC Counter-Selection Kit, and BAC Subcloning Kit to non-commercial, research organisations. Commercial companies require a license from Gene Bridges.
CAMBIO sees the Red/ET kits as an ideal complement to their range of BAC libraries. Together they represent the key resources necessary for researchers to produce transgenic models with unprecedented ease. Now investigators can easily select and quickly obtain the BAC genomic sequence paired with the Red/ET kits for rapid production of transgenic constructs rather than labouring through the time-consuming process of subcloning and ligations. The Red/ET product line further extends CAMBIO's portfolio of products that expand investigators access to tools for systems biology."
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Ahead of the games: Test will catch sports cheats on new endurance drugs
Opening the cavity floodgates - Biochemists investigate the transport of large proteins through bacterial cell membranes
Watermelon genome decoded - Decoded genome paves way for better watermelons
BIO White Paper Dispels Over-Patenting Myth - Patenting is a Critical Element in Fostering Research and Development
Dow acquires Rohm and Haas, creating world's leading specialty chemicals and advanced materials company - $18.8 billion transaction marks pivotal point in Dow's transformation
Cells stop dividing when this gene kicks into high gear
Targeted test for antibiotic resistance in clinical Enterobacter species - New discovery enables targeted antibiotic therapy
Varian, Inc. Announces Unique Probe Technology Breakthrough for Biological Solids NMR
Breakthrough Discovery Sheds Light on Heart and Muscle Health - Scientists shoot first true-to-life 3D image of the thick filament of mammalian heart muscle
Diagnosis just a breath away with new laser
MIT nanotubes sniff out cancer agents in living cells - Chemical engineers use carbon nanotubes to monitor chemotherapy, detect toxins at the single-molecule level
